78 / 187
76
Tradelink Electronic Commerce Limited
Annual Report 2017
Directors’ Report
(Continued)
董事會報告書
（續）
Share Option Scheme 2005
Under the Share Option Scheme 2005, the Board has the absolute
discretion to offer any employees (whether full-time or part-time),
directors (including Independent Non-executive Directors), consultants,
business associates or advisers of the Company or any company within
the Group options to subscribe for shares, provided that the total
number of shares issued or to be issued to any one grantee in any 12
month period does not exceed 1% of the shares of the Company in
issue. The grantee shall pay HK$1.00 to the Company as nominal
consideration for the grant upon acceptance of the offer of an option.
Each option has a 10-year exercise period. Commencing from the first,
second and third anniversaries of the grant of the options, the relevant
grantee may exercise up to 25%, 60% and 100% respectively of the
share options (less any number of shares in respect of which the options
have been previously exercised).
The purpose of the Share Option Scheme 2005 is to assist the Company
to attract and retain the best available personnel and to provide
additional incentives to employees, directors, consultants, business
associates and advisers to promote the success of the Group.
The total number of shares which may be issued upon exercise of all
options to be granted under the Share Option Scheme 2005 shall not
exceed in aggregate 10% of the issued capital of the Company at its
adoption date, being 77,763,250 ordinary shares (the “Scheme Mandate
Limit”). Options that have lapsed shall not be counted for the purpose
of calculating the Scheme Mandate Limit. The Scheme Mandate Limit
may be renewed by obtaining approval of shareholders in general
meetings of the Company provided that such total number of shares
which may be issued upon exercise of all options to be granted under
the Share Option Scheme 2005 under the Scheme Mandate Limit as
renewed shall not exceed 10% of the shares issued at the date of
approval of such limit (the “Refreshed Limit”). Options previously
granted (including those outstanding, cancelled, lapsed or exercised)
shall not be counted for the purpose of calculating the Refreshed Limit.
The subscription amount payable in respect of each share option upon
exercise of an option is determined by the Board and may not be less
than the greater of:
(i)
the closing price of the shares on the SEHK’s daily quotation sheet
on the date, which must be a business day, of a written offer of
such option (the “Date of Grant”);
(ii)
the average closing price of the shares on the SEHK as stated in
the SEHK’s daily quotation sheets for the five business days
immediately preceding the Date of Grant; and
二零零五年購股權計劃
根據二零零五年購股權計劃，董事會可全權酌情
向本公司或本集團旗下任何公司的任何僱員（不
論全職或兼職）、董事（包括獨立非執行董事）、專
業顧問、業務夥伴或諮詢顧問授出可認購股份的
購股權，惟任何十二個月期間內已發行或將發行
予任何一名承授人的股份總數不得超過本公司已
發行股份的
1%
。接納購股權要約時，承授人須
向本公司支付港幣
1.00
元，作為獲授購股權的象
徵式代價。每份購股權的行使期均為十年。由獲
授購股權之日起計第一、第二及第三週年開始，
相關承授人可分別行使購股權認購不超過
25%
、
60%
及
100%
的所涉股份（須減去過往已行使的購
股權所涉任何股份數目）。
二零零五年購股權計劃之目的在於協助本公司吸
引及留聘最佳員工，並為僱員、董事、專業顧
問、業務夥伴及諮詢顧問提供額外獎勵，以促進
本集團成功。
根據二零零五年購股權計劃將予授出的所有購股
權予以行使時可予發行的股份總數，合共不得超
過 本 公 司 於 採 納 日 期 的 已 發 行 股 本
10%
（即
77,763,250
股普通股）（「計劃授權限額」）。在計算
計劃授權限額時，已失效的購股權不得計算在
內。計劃授權限額可於本公司股東大會上取得股
東批准後更新，惟按更新後的計劃授權限額，根
據二零零五年購股權計劃將予授出的所有購股權
予以行使時可予發行的該股份總數，不得超過批
准該限額當日已發行股份的
10%
（「經更新限
額」）。就計算經更新限額而言，以往授出的購股
權（包括尚未行使、已註銷、失效或行使者）不得
計算在內。
因行使購股權而須就每份購股權支付的認購款項
由董事會釐定，且不得少於下列較高者：
(i)
於購股權的書面要約日期（「授出日期」，必
須為營業日），股份於香港聯交所每日報價
表所列的收市價；
(ii)
緊接授出日期前五個營業日，股份於香港
聯交所每日報價表所列在香港聯交所的平
均收市價；及